1. Home
  2. AMED vs RDY Comparison

AMED vs RDY Comparison

Compare AMED & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMED
  • RDY
  • Stock Information
  • Founded
  • AMED 1982
  • RDY 1984
  • Country
  • AMED United States
  • RDY India
  • Employees
  • AMED N/A
  • RDY N/A
  • Industry
  • AMED Medical/Nursing Services
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMED Health Care
  • RDY Health Care
  • Exchange
  • AMED Nasdaq
  • RDY Nasdaq
  • Market Cap
  • AMED 2.8B
  • RDY 2.5B
  • IPO Year
  • AMED N/A
  • RDY N/A
  • Fundamental
  • Price
  • AMED $92.80
  • RDY $14.02
  • Analyst Decision
  • AMED Hold
  • RDY Buy
  • Analyst Count
  • AMED 5
  • RDY 1
  • Target Price
  • AMED $100.67
  • RDY $17.00
  • AVG Volume (30 Days)
  • AMED 439.6K
  • RDY 2.1M
  • Earning Date
  • AMED 02-19-2025
  • RDY 01-23-2025
  • Dividend Yield
  • AMED N/A
  • RDY 4.10%
  • EPS Growth
  • AMED 3058.49
  • RDY 2.68
  • EPS
  • AMED 2.52
  • RDY 0.75
  • Revenue
  • AMED $2,321,060,000.00
  • RDY $3,637,607,642.00
  • Revenue This Year
  • AMED $7.09
  • RDY $16.46
  • Revenue Next Year
  • AMED $5.18
  • RDY $8.84
  • P/E Ratio
  • AMED $36.83
  • RDY $18.88
  • Revenue Growth
  • AMED 4.19
  • RDY 14.74
  • 52 Week Low
  • AMED $82.15
  • RDY $13.61
  • 52 Week High
  • AMED $98.95
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • AMED 70.47
  • RDY 33.15
  • Support Level
  • AMED $91.81
  • RDY $14.72
  • Resistance Level
  • AMED $92.64
  • RDY $15.10
  • Average True Range (ATR)
  • AMED 0.71
  • RDY 0.28
  • MACD
  • AMED 0.15
  • RDY -0.18
  • Stochastic Oscillator
  • AMED 98.97
  • RDY 5.44

About AMED Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: